BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA. Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective. Prog Retin Eye Res 2018;62:77-119. [PMID: 28958885 DOI: 10.1016/j.preteyeres.2017.09.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Chmielarz-Czarnocińska A, Pawlak M, Szpecht D, Choręziak A, Szymankiewicz-Bręborowicz M, Gotz-Więckowska A. Management of retinopathy of prematurity (ROP) in a Polish cohort of infants. Sci Rep 2021;11:4522. [PMID: 33633248 DOI: 10.1038/s41598-021-83985-5] [Reference Citation Analysis]
2 Uemura A, Fukushima Y. Rho GTPases in Retinal Vascular Diseases. Int J Mol Sci 2021;22:3684. [PMID: 33916163 DOI: 10.3390/ijms22073684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Mutangana F, Muhizi C, Mudereva G, Noë P, Musiime S, Ngambe T, Tuyisenge L, Kumwami M, Nsabimana H, Conard C, Fonteyne Y, Casteels I, De Smedt S; Rwanda Retinopathy of Prematurity Study Group. Retinopathy of prematurity in Rwanda: a prospective multi-centre study following introduction of screening and treatment services. Eye (Lond) 2020;34:847-56. [PMID: 31363176 DOI: 10.1038/s41433-019-0529-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
4 Ilguy S, Cilingir O, Bilgec MD, Ozalp O, Erzurumluoglu Gokalp E, Arslan S, Tekin N, Aydemir O, Erol N, Colak E, Gursoy H. The relationship of retinopathy of prematurity with brain-derivated neurotrophic factor, vascular endotelial growth factor-A, endothelial PAD domain protein 1 and nitric oxide synthase 3 gene polymorphisms. Ophthalmic Genet 2021;:1-7. [PMID: 34346275 DOI: 10.1080/13816810.2021.1961279] [Reference Citation Analysis]
5 Zhang J, Zhu M, Ruan L, Jiang C, Yang Q, Chang Q, Huang X. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model. FASEB J 2020;34:15822-36. [PMID: 33103304 DOI: 10.1096/fj.202001295R] [Reference Citation Analysis]
6 Yılmaz FH, Tutar MS, Arslan D, Çeri A. Readability, understandability, and quality of retinopathy of prematurity information on the web. Birth Defects Res 2021;113:901-10. [PMID: 33594835 DOI: 10.1002/bdr2.1883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Na KH, Kim KH, Kang TU, Hann HJ, Ahn HS, Kim HJ. Incidence, Long-Term Visual Outcomes, and Mortality in Retinopathy of Prematurity in Korea: A Nationwide Population-Based Study. Invest Ophthalmol Vis Sci 2020;61:14. [PMID: 32761140 DOI: 10.1167/iovs.61.10.14] [Reference Citation Analysis]
8 Morrison SL, Dukhovny D, Chan RVP, Chiang MF, Campbell JP. Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening. JAMA Ophthalmol 2022. [PMID: 35297945 DOI: 10.1001/jamaophthalmol.2022.0223] [Reference Citation Analysis]
9 Gudlavalleti VS, Shukla R, Batchu T, Malladi BVS, Gilbert C. Public health system integration of avoidable blindness screening and management, India. Bull World Health Organ 2018;96:705-15. [PMID: 30455518 DOI: 10.2471/BLT.18.212167] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Bulka CM, Dammann O, Santos HP Jr, VanderVeen DK, Smeester L, Fichorova R, O'Shea TM, Fry RC. Placental CpG Methylation of Inflammation, Angiogenic, and Neurotrophic Genes and Retinopathy of Prematurity. Invest Ophthalmol Vis Sci 2019;60:2888-94. [PMID: 31266060 DOI: 10.1167/iovs.18-26466] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zhou H, Song H, Wu Y, Liu X, Li J, Zhao H, Tang M, Ji X, Zhang L, Su Y, He Y, Feng K, Jiao Y, Xu H. Oxygen-induced circRNA profiles and coregulatory networks in a retinopathy of prematurity mouse model. Exp Ther Med 2019;18:2037-50. [PMID: 31452702 DOI: 10.3892/etm.2019.7819] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Huang R, Xu Y, Lu X, Tang X, Lin J, Cui K, Yu S, Shi Y, Ye D, Liu Y, Liang X. Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia. J Pineal Res 2021;71:e12716. [PMID: 33426650 DOI: 10.1111/jpi.12716] [Reference Citation Analysis]
13 Shiraki A, Fukushima Y, Kawasaki R, Sakaguchi H, Mitsuhashi M, Ineyama H, Hatsukawa Y, Nishida K. Retrospective Validation of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Criteria in a Japanese Cohort. American Journal of Ophthalmology 2019;205:50-3. [DOI: 10.1016/j.ajo.2019.03.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Acar DE, Acar U, Tunay ZO, Arman A, Goksuluk D. Retinal choroidal and retinal nerve fiber layer thickness in former preterm and full-term infants aged 4 to 8 years. Int Ophthalmol 2021;41:1071-9. [PMID: 33387107 DOI: 10.1007/s10792-020-01666-0] [Reference Citation Analysis]
15 Enríquez AB, Avery RL, Baumal CR. Update on Anti-Vascular Endothelial Growth Factor Safety for Retinopathy of Prematurity. Asia Pac J Ophthalmol (Phila) 2020;9:358-68. [PMID: 32694348 DOI: 10.1097/APO.0000000000000302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lavric A, Markelj S, Ding J, Mahajan S, Agrawal R, Tekavcic Pompe M. Perinatal risk factors associated with central retinal changes in former preterm children on optical coherence tomography angiography. Acta Ophthalmol 2021. [PMID: 33829666 DOI: 10.1111/aos.14870] [Reference Citation Analysis]
17 Chen S, Sun Q, Sun D, Willette-Brown J, Anderson MJ, Gu Q, Lewandoski M, Hu Y, Zhu F, Wei F, Zhang J. C-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development. Biomed Pharmacother 2020;132:110856. [PMID: 33125970 DOI: 10.1016/j.biopha.2020.110856] [Reference Citation Analysis]
18 Darlow BA, Husain S. Primary prevention of ROP and the oxygen saturation targeting trials. Semin Perinatol 2019;43:333-40. [PMID: 31151776 DOI: 10.1053/j.semperi.2019.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Fukushima Y, Kawasaki R, Sakaguchi H, Winegarner A, Ineyama H, Imanishi Y, Hirano S, Wada K, Hatsukawa Y, Nishida K. Characterization of the Progression Pattern in Retinopathy of Prematurity Subtypes. Ophthalmol Retina 2020;4:231-7. [PMID: 31982389 DOI: 10.1016/j.oret.2019.11.015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Li R, Wang Y, Chen P, Meng J, Zhang H. G-protein-coupled estrogen receptor protects retinal ganglion cells via inhibiting endoplasmic reticulum stress under hyperoxia. J Cell Physiol 2021;236:3780-8. [PMID: 33151568 DOI: 10.1002/jcp.30149] [Reference Citation Analysis]
21 Villa F, Carrizzo A, Ferrario A, Maciag A, Cattaneo M, Spinelli CC, Montella F, Damato A, Ciaglia E, Puca AA. A Model of Evolutionary Selection: The Cardiovascular Protective Function of the Longevity Associated Variant of BPIFB4. Int J Mol Sci 2018;19:E3229. [PMID: 30347645 DOI: 10.3390/ijms19103229] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
22 AlBathi L, Abouammoh N, AlSwaina N, AlBalawi HB, Al Qahtani AA, Talea M, AlSulaiman SM, Abouammoh MA. Pitfalls of Advanced Retinopathy of Prematurity Presentation: A Content Analysis of Medical Records. Risk Manag Healthc Policy 2021;14:3873-82. [PMID: 34557046 DOI: 10.2147/RMHP.S326757] [Reference Citation Analysis]
23 Hu J, Bibli SI, Wittig J, Zukunft S, Lin J, Hammes HP, Popp R, Fleming I. Soluble epoxide hydrolase promotes astrocyte survival in retinopathy of prematurity. J Clin Invest 2019;129:5204-18. [PMID: 31479425 DOI: 10.1172/JCI123835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
24 Jian L, Mei Y, Xing C, Rongdi Y. Haem relieves hyperoxia-mediated inhibition of HMEC-1 cell proliferation, migration and angiogenesis by inhibiting BACH1 expression. BMC Ophthalmol 2021;21:104. [PMID: 33632168 DOI: 10.1186/s12886-021-01866-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kong HB, Zheng GY, He BM, Zhang Y, Zhou Q. Clinical Efficacy and Safety of Propranolol in the Prevention and Treatment of Retinopathy of Prematurity: A Meta-Analysis of Randomized Controlled Trials. Front Pediatr 2021;9:631673. [PMID: 33643978 DOI: 10.3389/fped.2021.631673] [Reference Citation Analysis]
26 Hombrebueno JR, Lynch A, Byrne EM, Obasanmi G, Kissenpfennig A, Chen M, Xu H. Hyaloid Vasculature as a Major Source of STAT3+ (Signal Transducer and Activator of Transcription 3) Myeloid Cells for Pathogenic Retinal Neovascularization in Oxygen-Induced Retinopathy. Arterioscler Thromb Vasc Biol 2020;40:e367-79. [PMID: 33115265 DOI: 10.1161/ATVBAHA.120.314567] [Reference Citation Analysis]
27 Huang Y, Zhang L, Sun H, Liu C, Yang Y, Lee SK, Cao Y, Jiang S. Neonatal outcome of small for gestational age infants born at 26-33 weeks' gestation in Chinese neonatal intensive care units. Transl Pediatr 2021;10:754-64. [PMID: 34012825 DOI: 10.21037/tp-20-339] [Reference Citation Analysis]
28 Fleming I. New Lipid Mediators in Retinal Angiogenesis and Retinopathy. Front Pharmacol 2019;10:739. [PMID: 31333461 DOI: 10.3389/fphar.2019.00739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Ai J, Ma J, Chen ZQ, Sun JH, Yao K. An Endostatin-lentivirus (ES-LV)-EPC gene therapy agent for suppression of neovascularization in oxygen-induced retinopathy rat model. BMC Mol Cell Biol 2020;21:57. [PMID: 32727534 DOI: 10.1186/s12860-020-00301-1] [Reference Citation Analysis]
30 Aranda JV, Qu J, Valencia GB, Beharry KD. Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity. Semin Perinatol 2019;43:360-6. [PMID: 31153620 DOI: 10.1053/j.semperi.2019.05.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
31 Dos Santos LRB, Fleming I. Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome. Prostaglandins Other Lipid Mediat 2020;148:106407. [PMID: 31899373 DOI: 10.1016/j.prostaglandins.2019.106407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 Park JY, Park CW, Moon KC, Park JS, Jun JK, Lee SJ, Kim JH. Retinopathy of prematurity in infants without fetal growth restriction is decreased with the progression of acute histologic chorioamnionitis: New observation as a protective factor against retinopathy of prematurity. Placenta 2021;104:161-7. [PMID: 33348284 DOI: 10.1016/j.placenta.2020.12.007] [Reference Citation Analysis]
33 Joyal JS, Gantner ML, Smith LEH. Retinal energy demands control vascular supply of the retina in development and disease: The role of neuronal lipid and glucose metabolism. Prog Retin Eye Res 2018;64:131-56. [PMID: 29175509 DOI: 10.1016/j.preteyeres.2017.11.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 9.6] [Reference Citation Analysis]
34 Dai C, Xiao J, Wang C, Li W, Su G. Neurovascular abnormalities in retinopathy of prematurity and emerging therapies. J Mol Med (Berl) 2022. [PMID: 35394143 DOI: 10.1007/s00109-022-02195-2] [Reference Citation Analysis]
35 Zhang C, Hu J, Yu Y. CircRNA Is a Rising Star in Researches of Ocular Diseases. Front Cell Dev Biol 2020;8:850. [PMID: 33015046 DOI: 10.3389/fcell.2020.00850] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
36 Martins TGDS, Andreghetto LDAF, Brito RM, Provenzano LB, Fowler S. Evaluation of the prematurity retinopathy and other eye changes in the newborn. Einstein (São Paulo) 2022;20:eAO6692. [DOI: 10.31744/einstein_journal/2022ao6692] [Reference Citation Analysis]
37 Alahmadi AS, Badawi AH, Magliyah MS, Albakri A, Schatz P. Poretti-Boltshauser syndrome: a rare differential diagnosis to consider in pediatric high myopia with retinal degeneration. Ophthalmic Genet 2021;42:96-8. [PMID: 33251915 DOI: 10.1080/13816810.2020.1849316] [Reference Citation Analysis]
38 Chen W, Zhang J, Zhang P, Hu F, Jiang T, Gu J, Chang Q. Role of TLR4-MAP4K4 signaling pathway in models of oxygen-induced retinopathy. FASEB J 2019;33:3451-64. [PMID: 30475644 DOI: 10.1096/fj.201801086RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Vinekar A, Nair AP, Sinha S, Vaidya T, Chakrabarty K, Shetty R, Ghosh A, Sethu S. Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants. Invest Ophthalmol Vis Sci 2021;62:2. [PMID: 33646290 DOI: 10.1167/iovs.62.3.2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Wang Z, Liu CH, Huang S, Chen J. Wnt Signaling in vascular eye diseases. Prog Retin Eye Res 2019;70:110-33. [PMID: 30513356 DOI: 10.1016/j.preteyeres.2018.11.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
41 Filippi L, Dal Monte M. A safety review of drugs used for the treatment of retinopathy of prematurity. Expert Opin Drug Saf 2020;19:1409-18. [PMID: 32954858 DOI: 10.1080/14740338.2020.1826927] [Reference Citation Analysis]
42 Tsai AS, Chou HD, Ling XC, Al-Khaled T, Valikodath N, Cole E, Yap VL, Chiang MF, Chan RVP, Wu WC. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Prog Retin Eye Res 2021;:101018. [PMID: 34763060 DOI: 10.1016/j.preteyeres.2021.101018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Daruich A, Bremond-Gignac D, Behar-Cohen F, Kermorvant E. [Retinopathy of prematurity: from prevention to treatment]. Med Sci (Paris) 2020;36:900-7. [PMID: 33026333 DOI: 10.1051/medsci/2020163] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Ingolfsland EC, Haapala JL, Buckley LA, Demarath EW, Guiang SF, Ramel SE. Late Growth and Changes in Body Composition Influence Odds of Developing Retinopathy of Prematurity among Preterm Infants. Nutrients 2019;12:E78. [PMID: 31892145 DOI: 10.3390/nu12010078] [Reference Citation Analysis]
45 Podraza W. A new approach to neonatal medical management that could transform the prevention of retinopathy of prematurity: Theoretical considerations. Med Hypotheses 2020;137:109541. [PMID: 31901610 DOI: 10.1016/j.mehy.2019.109541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Ozturk MA, Korkmaz L. The efficacy of propranolol in very preterm infants at the risk of retinopathy of prematurity: Which newborn and when? Int Ophthalmol 2019;39:1921-30. [PMID: 30229439 DOI: 10.1007/s10792-018-1018-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Gilbert C, Shukla R, Murthy GVS, Santosha BVM, Gudlavalleti AG, Mukpalkar S, Yamarthi P, Pendyala S, Puppala A, Edla S, Batchu T; India ROP Partners Implementation Consortium. Retinopathy of prematurity: Overview and highlights of an initiative to integrate prevention, screening, and management into the public health system in India. Indian J Ophthalmol 2020;68:S103-7. [PMID: 31937743 DOI: 10.4103/ijo.IJO_2080_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
48 Xu W, Wu Y, Hu Z, Sun L, Dou G, Zhang Z, Wang H, Guo C, Wang Y. Exosomes from Microglia Attenuate Photoreceptor Injury and Neovascularization in an Animal Model of Retinopathy of Prematurity. Mol Ther Nucleic Acids 2019;16:778-90. [PMID: 31163320 DOI: 10.1016/j.omtn.2019.04.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
49 Sommer AC, Blumenthal EZ. Telemedicine in ophthalmology in view of the emerging COVID-19 outbreak. Graefes Arch Clin Exp Ophthalmol 2020;258:2341-52. [PMID: 32813110 DOI: 10.1007/s00417-020-04879-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]